Vizient PSO Topical Safety Webinar - Preventing Chemotherapy Medication Errors

August 10, 2022

The presenters will describe strategies used in two different academical medical cancer centers to promote safe administration of chemotherapy. The presenters from MD Anderson will highlight critical points in the chemotherapy administration process where medication errors often occur and will offer mitigation strategies to prevent future errors from occurring. The presenters from Kansas University Medical Center Cancer Center will describe how they used quality improvement methodology to address and increase the safe administration of oral chemotherapy, including sustained completion of treatment in patients receiving oral chemotherapy.

Target Audience

Nurses

Physicians

Pharmacists

Learning Objectives

1.    Outline practical approaches to minimize medication errors with chemotherapeutic agents.  
2.    Describe best practices for timely approach to address gaps in the medication-use process upon reviewing voluntary reported events.
3.    Describe how data analysis was used to identify, track, and sustain oral chemotherapy safety improvements.
4.    Discuss interventions to foster safer oral chemotherapy workflows and demonstrate how improvement methods are used to sustain and monitor improvements.
 

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CEU – Attendance
Course opens: 
07/18/2022
Course expires: 
09/24/2022
Event starts: 
08/10/2022 - 1:00pm CDT
Event ends: 
08/10/2022 - 2:00pm CDT
Rating: 
0
Live activity
United States

Identification, Mitigation, and Disclosure of Relevant Financial Relationships 
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months. 

Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States. 

DISCLOSURE STATEMENTS:

Absence of Relevant Financial Relationships
The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.

Planning committee members

Ellen Flynn, RN, MBA, JD, CPPS
AVP, PSO Program
Vizient

Tammy Williams, MSN, RN, CPPS
Program Director
Vizient

Kathryn Merkeley, MHSA, RN, PMP, CPPS
Program Director
Vizient

Jay Prystowski, MD, MBA
Principal
Vizient

James Lichauer, Pharm.D., BCPS, FASHP
PI Program Director Pharmacy
Vizient

Speakers

Patrick Sayer Monroe, Pharm.D., CJCP, CMQ
Medication Safety Consultant
The University of Texas MD Anderson Cancer Center

Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP, CMQ
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center

Marshall A.F. Johnson, PharmD, MHA
Pharmacy Clinical Coordinator: Oral Chemotherapy & Specialty Pharmacy
Kansas University Medical Center Cancer Center

Adam Neiberger, MPH
Quality Improvement Coordinator II
Kansas University Medical Center Cancer Center
 

 

Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement:

NURSING
This activity is designated for 1.00 contact hours.

Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.00 contact hours.

PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours. 
Universal Activity Number: JA0006103-0000-22-051-L05-P

PHYSICIAN
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CEU – Attendance
Please login or register to take this course.